Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Zipursky

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|January 28, 2025
Global Impact of Mass Vaccination Campaigns on Circulating Type 2 Vaccine-Derived Poliovirus Outbreaks: An Interrupted Time-Series AnalysisLaura V Cooper, Ananda S Bandyopadhyay, Nicholas C Grassly, et al.
Vaccine|June 25, 2011
Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in ChadSimona Zipursky, Liliane Boualam, Dah Ould Cheikh, et al.
The Journal of Infectious Diseases|August 26, 2017
Polio Endgame: Lessons Learned From the Immunization Systems Management GroupSimona Zipursky, Jos Vandelaer, Alan Brooks, et al.
The Journal of Infectious Diseases|August 26, 2017
Financial Support to Eligible Countries for the Switch From Trivalent to Bivalent Oral Polio Vaccine-Lessons LearnedStephanie Shendale, Margaret Farrell, Lee M Hampton, et al.
Bulletin of the World Health Organization|February 12, 2013
Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributesOsman David Mansoor, Debra Kristensen, Andrew Meek, et al.
Vaccine|March 21, 2022
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experienceGrace R Macklin, Corey Peak, Martin Eisenhawer, et al.
The Journal of Infectious Diseases|August 26, 2017
Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio EndgameSimona Zipursky, Manish Patel, Margaret Farrell, et al.
Vaccine|September 28, 2014
A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chainAitana Juan-Giner, Camille Domicent, Céline Langendorf, et al.
Pathogens (Basel, Switzerland)|April 26, 2024
Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health EmergencyFeyrouz Damji Kurji, Ananda Sankar Bandyopadhyay, Simona Zipursky, et al.
MMWR. Morbidity and Mortality Weekly Report|September 21, 2023
Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use - Six African Countries, 2021-2023Elizabeth Davlantes, Jaume Jorba, Elizabeth Henderson, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|January 28, 2025
Global Impact of Mass Vaccination Campaigns on Circulating Type 2 Vaccine-Derived Poliovirus Outbreaks: An Interrupted Time-Series AnalysisLaura V Cooper, Ananda S Bandyopadhyay, Nicholas C Grassly, et al.
Vaccine|June 25, 2011
Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in ChadSimona Zipursky, Liliane Boualam, Dah Ould Cheikh, et al.
The Journal of Infectious Diseases|August 26, 2017
Polio Endgame: Lessons Learned From the Immunization Systems Management GroupSimona Zipursky, Jos Vandelaer, Alan Brooks, et al.
The Journal of Infectious Diseases|August 26, 2017
Financial Support to Eligible Countries for the Switch From Trivalent to Bivalent Oral Polio Vaccine-Lessons LearnedStephanie Shendale, Margaret Farrell, Lee M Hampton, et al.
Bulletin of the World Health Organization|February 12, 2013
Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributesOsman David Mansoor, Debra Kristensen, Andrew Meek, et al.
Vaccine|March 21, 2022
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experienceGrace R Macklin, Corey Peak, Martin Eisenhawer, et al.
The Journal of Infectious Diseases|August 26, 2017
Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio EndgameSimona Zipursky, Manish Patel, Margaret Farrell, et al.
Vaccine|September 28, 2014
A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chainAitana Juan-Giner, Camille Domicent, Céline Langendorf, et al.
Pathogens (Basel, Switzerland)|April 26, 2024
Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health EmergencyFeyrouz Damji Kurji, Ananda Sankar Bandyopadhyay, Simona Zipursky, et al.
MMWR. Morbidity and Mortality Weekly Report|September 21, 2023
Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use - Six African Countries, 2021-2023Elizabeth Davlantes, Jaume Jorba, Elizabeth Henderson, et al.
Pageof 3